(Q36189960)

12 August 2017

A novel long-acting human growth hormone fusion protein (VRS-317): enhanced in vivo potency and half-life (English)

1 reference

12 August 2017

Jeffrey L Cleland

1

1 reference

12 August 2017

Nathan C Geething

2

1 reference

12 August 2017

Jerome A Moore

3

1 reference

12 August 2017

Brian C Rogers

4

1 reference

12 August 2017

Benjamin J Spink

5

1 reference

12 August 2017

Chai-Wei Wang

6

1 reference

12 August 2017

Susan E Alters

7

1 reference

12 August 2017

Willem P C Stemmer

8

1 reference

12 August 2017

Volker Schellenberger

9

1 reference

12 August 2017

language of work or name

English

0 references

publication date

7 June 2012

1 reference

Journal of Pharmaceutical Sciences

12 August 2017

1 reference

12 August 2017

101

1 reference

12 August 2017

8

1 reference

12 August 2017

2744-2754

1 reference

Identification of the glomerular podocyte as a target for growth hormone action

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

A novel bioassay for human somatogenic activity in serum samples supports the clinical reliability of immunoassays.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient ad

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

A month-long effect from a single injection of microencapsulated human growth hormone

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

Stability and characterization of human growth hormone

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

Cellular mechanisms in the processing of growth hormone and its receptor.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

Renal extraction, filtration, absorption, and catabolism of growth hormone

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD).

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

Compliance and persistence in pediatric and adult patients receiving growth hormone therapy

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3427893

Intracellular processing of growth hormone receptors by adipocytes in primary culture

5 December 2018

1 reference

12 December 2020

Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices

1 reference

12 December 2020

Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children

1 reference

12 December 2020

Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients

1 reference

12 December 2020

Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH

1 reference

12 December 2020

Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency

1 reference

12 December 2020

Long-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Identifiers

DOI

10.1002/JPS.23229

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22678811

1 reference